Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys.


Journal

Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645

Informations de publication

Date de publication:
10 Feb 2019
Historique:
received: 19 06 2018
accepted: 23 01 2019
entrez: 11 2 2019
pubmed: 11 2 2019
medline: 23 3 2019
Statut: epublish

Résumé

Onchocerciasis-endemic regions are known to have a high epilepsy prevalence. Limited resources in these areas and poor access to healthcare by persons with epilepsy (PWE) result in a wide anti-epileptic treatment gap, poor seizure control and a high burden of seizure-related complications. Recent community-based surveys highlight the need for epilepsy management strategies suitable for remote onchocerciasis-endemic villages to ensure better health outcomes for PWE. In this paper, we propose a feasible approach to manage PWE in such settings. Improved management of PWE in onchocerciasis-endemic areas may be achieved by decentralizing epilepsy care. Simplified approaches for the diagnosis and treatment of epilepsy may be used by non-physicians, under the supervision of physicians or specialists. To reduce the treatment gap, a regular supply of subsidized anti-epileptic drugs (AED) appropriate for different types of onchocerciasis-associated epilepsy should be instituted. Setting up a community-based epilepsy surveillance system will enable early diagnosis and treatment of PWE thereby preventing complications. Community awareness programs on epilepsy must be implemented to reduce stigma and facilitate the social rehabilitation of PWE. Finally, strengthening onchocerciasis elimination programs by optimizing community-directed treatment with ivermectin (CDTI) and considering alternative treatment strategies might reduce the incidence of epilepsy. A community-based approach with task-shifting of epilepsy care from specialists to non-physician health workers will reduce epilepsy-associated morbidity. Increased advocacy and collaboration with various stakeholders is needed to establish a sustainable, cost-effective chronic care model for epilepsy that will significantly improve the quality of life of PWE in onchocerciasis-endemic regions.

Sections du résumé

BACKGROUND BACKGROUND
Onchocerciasis-endemic regions are known to have a high epilepsy prevalence. Limited resources in these areas and poor access to healthcare by persons with epilepsy (PWE) result in a wide anti-epileptic treatment gap, poor seizure control and a high burden of seizure-related complications. Recent community-based surveys highlight the need for epilepsy management strategies suitable for remote onchocerciasis-endemic villages to ensure better health outcomes for PWE. In this paper, we propose a feasible approach to manage PWE in such settings.
MAIN TEXT METHODS
Improved management of PWE in onchocerciasis-endemic areas may be achieved by decentralizing epilepsy care. Simplified approaches for the diagnosis and treatment of epilepsy may be used by non-physicians, under the supervision of physicians or specialists. To reduce the treatment gap, a regular supply of subsidized anti-epileptic drugs (AED) appropriate for different types of onchocerciasis-associated epilepsy should be instituted. Setting up a community-based epilepsy surveillance system will enable early diagnosis and treatment of PWE thereby preventing complications. Community awareness programs on epilepsy must be implemented to reduce stigma and facilitate the social rehabilitation of PWE. Finally, strengthening onchocerciasis elimination programs by optimizing community-directed treatment with ivermectin (CDTI) and considering alternative treatment strategies might reduce the incidence of epilepsy.
CONCLUSIONS CONCLUSIONS
A community-based approach with task-shifting of epilepsy care from specialists to non-physician health workers will reduce epilepsy-associated morbidity. Increased advocacy and collaboration with various stakeholders is needed to establish a sustainable, cost-effective chronic care model for epilepsy that will significantly improve the quality of life of PWE in onchocerciasis-endemic regions.

Identifiants

pubmed: 30738437
doi: 10.1186/s40249-019-0523-y
pii: 10.1186/s40249-019-0523-y
pmc: PMC6368958
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Subventions

Organisme : Medical Research Council
ID : MR/M025489/1
Pays : United Kingdom
Organisme : European Research Council
ID : 768815
Pays : International

Références

J Caring Sci. 2017 Mar 01;6(1):59-65
pubmed: 28299298
Glob Health Action. 2018;11(1):1431362
pubmed: 29382251
Epilepsia. 2010 Apr;51(4):671-5
pubmed: 19732133
Arch Pediatr. 2016 Feb;23(2):204-9
pubmed: 26697814
Epilepsia Open. 2017 Apr 26;2(2):145-152
pubmed: 29588943
Emerg Themes Epidemiol. 2012 Nov 21;9(1):8
pubmed: 23171721
Curr Treat Options Neurol. 2013 Aug;15(4):529-43
pubmed: 23657845
Epilepsia Open. 2018 Jan 23;3(1):66-72
pubmed: 29588989
Isr Med Assoc J. 2003 Jul;5(7):522-3
pubmed: 12901252
Epilepsia. 2008 Dec;49 Suppl 9:43-55
pubmed: 19087117
Epilepsy Behav. 2018 Feb;79:23-25
pubmed: 29245111
J Med Genet. 2002 Apr;39(4):248-50
pubmed: 11950852
PLoS Negl Trop Dis. 2009 Jun 16;3(6):e461
pubmed: 19529767
Cochrane Database Syst Rev. 2016 Nov 07;11:CD010224
pubmed: 27819746
PLoS Negl Trop Dis. 2012;6(9):e1825
pubmed: 23029586
Trans R Soc Trop Med Hyg. 2007 Jan;101(1):48-55
pubmed: 16905166
Infect Dis Poverty. 2018 Sep 19;7(1):101
pubmed: 30253788
Epilepsy Behav. 2010 Jan;17(1):95-102
pubmed: 19932640
Epilepsia. 2003 Jul;44(7):956-63
pubmed: 12823580
Epileptic Disord. 2015 Mar;17(1):13-8; quiz 18
pubmed: 25635346
Epilepsia. 1997 Sep;38(9):1054-6
pubmed: 9579949
Trends Parasitol. 2018 Mar;34(3):208-216
pubmed: 29288080
Clin Infect Dis. 2017 Nov 29;65(12):2026-2034
pubmed: 29020189
Afr Health Sci. 2013 Sep;13(3):613-23
pubmed: 24250298
Clin Infect Dis. 2016 Jun 1;62(11):1338-1347
pubmed: 27001801
Indian Pediatr. 2014 Jul;51(7):539-43
pubmed: 25031131
Epilepsia. 2004 Jun;45(6):667-72
pubmed: 15144432
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Infect Dis Poverty. 2018 Aug 1;7(1):68
pubmed: 30064504
PLoS Negl Trop Dis. 2013;7(3):e2147
pubmed: 23556028
JMIR Res Protoc. 2017 Aug 30;6(8):e137
pubmed: 28855148
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
BMJ Open. 2014 Nov 14;4(11):e006476
pubmed: 25398677
Infect Dis Poverty. 2018 Mar 22;7(1):23
pubmed: 29580280
Epilepsia Open. 2017 Mar 30;2(2):226-235
pubmed: 29588951
Bull Soc Pathol Exot. 2006 May;99(2):103-7
pubmed: 16821440
Int J Infect Dis. 2016 Mar;44:61-3
pubmed: 26845444
Public Health. 2006 May;120(5):448-50
pubmed: 16524608
Epilepsia. 2009 Sep;50(9):2167-8
pubmed: 19706061
Semin Pediatr Neurol. 2014 Mar;21(1):36-41
pubmed: 24655403
Int Health. 2018 Mar 1;10(suppl_1):i40-i48
pubmed: 29471342
Infect Dis Poverty. 2018 Dec 3;7(1):114
pubmed: 30501640
PLoS One. 2015 Jun 08;10(6):e0129097
pubmed: 26053071
Bull World Health Organ. 1996;74(4):361-7
pubmed: 8823957
Circulation. 2015 Oct 20;132(16 Suppl 1):S2-39
pubmed: 26472854
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Continuum (Minneap Minn). 2016 Feb;22(1 Epilepsy):204-26
pubmed: 26844738
PLoS One. 2017 Mar 16;12(3):e0173945
pubmed: 28301557
Front Public Health. 2014 Aug 21;2:120
pubmed: 25191650
Bull World Health Organ. 2010 Apr;88(4):260-6
pubmed: 20431789
PLoS Negl Trop Dis. 2017 Feb 9;11(2):e0005201
pubmed: 28182652
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319

Auteurs

Joseph Nelson Siewe Fodjo (JN)

Global Health Institute, University of Antwerp, Antwerp, Belgium. josephnelson.siewefodjo@uantwerpen.be.

Marieke C J Dekker (MCJ)

Department of Internal Medicine and Pediatrics, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Richard Idro (R)

Department of Paediatrics and Child Health, Makerere University, College of Health Sciences, Kampala, Uganda.

Michel Ndahura Mandro (MN)

Global Health Institute, University of Antwerp, Antwerp, Belgium.
Provincial Health Division Ituri, Ministry of Health, Bunia, Democratic Republic of the Congo.

Pierre-Marie Preux (PM)

INSERM, Univ. Limoges, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, GEIST, 87000, Limoges, CHU, UMR 1094, Limoges, France.

Alfred K Njamnshi (AK)

Department of Neurology, Yaoundé Central Hospital / FMBS, The University of Yaoundé 1, Yaoundé, Cameroon.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.

Robert Colebunders (R)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH